Oxford Ledge
Search
SANUWAVE Health, Inc. (NASDAQ: SNWV) is a $40M medical - devices company trading at $4.70 — 11.5× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-10-11 00:49 UTC.
Sanuwave is a medical device company that develops and markets directed energy products for wound care using ultrasound technology. The company's primary product is the UltraMIST system, which delivers low-frequency ultrasound through a fluid mist to treat acute and chronic wounds such as diabetic foot ulcers and pressure injuries. The UltraMIST system has received FDA clearance and CMS reimbursement, and operates on a business model where customers purchase the device and then buy sterile, single-use applicators for each treatment.
Summarized from SANUWAVE Health, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
| Quote | |
| Price | $4.70 |
| Market cap | $40M |
| Volume | 38.5K shares |
| Valuation | |
| P/E (FY2025) | 11.46× |
| EV/EBITDA | 8.40× |
| EPS (FY2025) | $0.41 |
| Price/book | 24.71× |
| Return on equity | 729.65% |
| Debt/equity | 13.52 |
Sanuwave is a medical device company that develops and markets directed energy products for wound care using ultrasound technology.
SNWV trades at $4.70, 11.46× trailing earnings, 8.40× EV/EBITDA, as of 2026-10-11.
SANUWAVE Health, Inc.'s most recent SEC filing on record is a 8-K filed 2026-09-25. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-10-11 00:49 UTC. This page is also available as JSON at /api/data?ticker=SNWV and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for SNWV and 5,000+ tickers.
Create a free account — keep SNWVGET /api/data?ticker=SNWV
This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt